Five Conditions One Scan
RetGuard detects ocular, cardiovascular, and metabolic disease from a single retinal scan at the point of care — enabling diabetic clinics to identify at-risk patients early and refer them for timely treatment.
Diabetic patients are losing their sight — silently
Over 500 million people with diabetes are at risk of retinal diseases like Diabetic Retinopathy and Macular Edema — conditions that cause irreversible blindness with zero early symptoms. Yet most never receive a single screening. The gap isn't treatment. It's access to early detection.
One scan. Five sight-threatening conditions.
RetGuard screens for Diabetic Retinopathy, Diabetic Macular Edema, Glaucoma, Age-Related Macular Degeneration, and Hypertensive Retinopathy — all in under 30 seconds. On-device AI. No cloud. No internet. Complete patient privacy.
Three steps. Thirty seconds.
That's it.
Capture
A quick, painless retinal image using the RetGuard camera. Built-in quality checks ensure only optimal images proceed.
Analyze
On-device AI screens for all five conditions simultaneously. Each result includes a calibrated confidence score.
Report
A structured clinical PDF is generated with results, visual evidence, and referral recommendations — in under 30 seconds.